Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction.
(2015) In Europace 17(2). p.255-261- Abstract
- International guidelines advocate an implantable cardioverter and defibrillator (ICD) in patients with reduced left ventricular ejection fraction (LVEF) to prevent sudden death (SCD). Previous data suggest that the benefit of ICD therapy in real life may be lower than expected from the results of controlled studies and side-effects are not negligible. It is also unclear whether women benefit from treatment to the same extent as men. The aim of this study was to investigate the balance between benefits and complications of ICD therapy in a real-life population of patients with heart failure.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4691859
- author
- Sjöblom, J ; Kalm, T ; Gadler, F ; Ljung, L ; Frykman, V ; Rosenqvist, M ; Platonov, Pyotr LU and Borgquist, Rasmus LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Europace
- volume
- 17
- issue
- 2
- pages
- 255 - 261
- publisher
- Oxford University Press
- external identifiers
-
- pmid:25210024
- wos:000351601600016
- scopus:84922429729
- pmid:25210024
- ISSN
- 1532-2092
- DOI
- 10.1093/europace/euu219
- language
- English
- LU publication?
- yes
- id
- 9402d666-a079-469c-bd1f-0d9991ca9e9d (old id 4691859)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25210024?dopt=Abstract
- date added to LUP
- 2016-04-01 11:10:32
- date last changed
- 2022-03-27 22:56:40
@article{9402d666-a079-469c-bd1f-0d9991ca9e9d, abstract = {{International guidelines advocate an implantable cardioverter and defibrillator (ICD) in patients with reduced left ventricular ejection fraction (LVEF) to prevent sudden death (SCD). Previous data suggest that the benefit of ICD therapy in real life may be lower than expected from the results of controlled studies and side-effects are not negligible. It is also unclear whether women benefit from treatment to the same extent as men. The aim of this study was to investigate the balance between benefits and complications of ICD therapy in a real-life population of patients with heart failure.}}, author = {{Sjöblom, J and Kalm, T and Gadler, F and Ljung, L and Frykman, V and Rosenqvist, M and Platonov, Pyotr and Borgquist, Rasmus}}, issn = {{1532-2092}}, language = {{eng}}, number = {{2}}, pages = {{255--261}}, publisher = {{Oxford University Press}}, series = {{Europace}}, title = {{Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction.}}, url = {{https://lup.lub.lu.se/search/files/2438912/5336544.pdf}}, doi = {{10.1093/europace/euu219}}, volume = {{17}}, year = {{2015}}, }